Related Experiment Videos
Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics
Julie A Ribes1, Angela Smith, Marie Hayes
1Department of Clinical Sciences, University of Kentucky, Lexington, Kentucky 40536-0298, USA. jaribes@uky.edu
Journal of Clinical Microbiology
|March 7, 2002
Summary
Two new herpes simplex virus type 1 enzyme immunoassays from MRL and Meridian Diagnostics show high accuracy. Both Food and Drug Administration-approved tests are suitable for clinical laboratory use.
Area of Science:
- Clinical diagnostics
- Virology
- Immunology
Background:
- Herpes simplex virus type 1 (HSV-1) is a common human pathogen.
- Accurate type-specific diagnostic assays are crucial for clinical management.
Purpose of the Study:
- To evaluate the performance of two Food and Drug Administration-approved HSV-1 type-specific enzyme immunoassays.
Main Methods:
- Assessed sensitivity, specificity, and overall testing efficiency.
- Compared MRL Diagnostics and Meridian Diagnostics HSV-1 assays.
Main Results:
- MRL assay: 98.2% sensitivity, 93.8% specificity, 96.6% efficiency.
- Meridian assay: 98.8% sensitivity, 99.0% specificity, 98.1% efficiency.
Conclusions:
- Both MRL and Meridian Diagnostics HSV-1 enzyme immunoassays demonstrate high diagnostic performance.
- These assays are suitable for routine use in clinical laboratories.